Initial LDH level can predict the survival benefit from bevacizumab in the first-line setting in Chinese patients with metastatic colorectal cancer

BACKGROUND: Markers to predict the efficacy of bevacizumab treatment have been not fully validated in most cancers, including metastatic colorectal cancer (mCRC). The aim of this study was to investigate the potential role of lactate dehydrogenase (LDH) in predicting the survival benefit from first-...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Yin, Chenxi, Jiang, Chang, Liao, Fangxin, Rong, Yuming, Cai, Xiuyu, Guo, Guifang, Qiu, Huijuan, Chen, Xuxian, Zhang, Bei, He, Wenzhuo, Xia, Liangping
Format: Artigo
Sprog:Inglês
Udgivet: Dove Medical Press 2014
Fag:
Original Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4136961/
https://ncbi.nlm.nih.gov/pubmed/25143746
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S64559
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker